Pharma

AstraZeneca CEO ‘Would Engage With Pfizer’ for the Right Price

Valeant Says It Will Boost Allergan Bid

Allergan Rejects Valeant’s $47 Billion Bid as Shire Buys Lumena

Pfizer Hits Back at Criticis of Proposed AstraZeneca Deal

UK Prime Minister Calls on Pfizer for More Guarantees

Topics • Strategy

Devalued and Distrusted

Topics • Strategy

Evolution of a Dynamic Healthcare Market

Topics • Strategy

International Drugmakers Meet Challenges

UK May Use Public Interest Against Pfizer’s AstraZeneca Bid

Pfizer Ups Offer for AstraZeneca to $106 Billion

Merck Consumer Unit Said to be Worth $14 Billion for Bayer

Sanofi Said Eyeing Drug Divestments of Over $7 Billion

Pfizer Chases AstraZeneca for Potential $100 billion Deal

Actavis Sues FDA Over Generic of Pfizer’s Celebrex

Bayer and Reckitt Said Finalists for Merck & Co. Consumer Arm

Valeant, Ackman Make $47 billion offer for Allergan

Pfizer Said to be Interested in AstraZeneca

Novartis and Lilly Clinch Animal Health Deal

Novartis and GlaxoSmithKline Swap $20 Billion in Assets

Roche Rejects Criticism of Tamiflu

U.S. Sanofi Executive Sentenced for Insider Trading

BASF Plans New Specialty Amines Plant in Ludwigshafen

GSK Faces Criminal Bribery Investigation in Poland

Amgen Ends Non-U.S. Co-Marketing Pact With GSK

GlaxoSmithKine Investigates Alleged Bribery in Iraq

India’s Sun Pharmaceutical to Buy Compatriot Ranbaxy

Teva Asks U.S. Supreme Court to Stay Copaxone Ruling

Swedish Drugmaker Meda Spurns Mylan Approach

Topics • Technology

GDUFA’s Impact on the API Industry – an Update

Novartis Ends Heart Failure Drug Tests Early on Strong Results

U.S. Justices Agree to Hear Teva's Copaxone Appeal

GSK Combined Melanoma Treatment Delayed in Europe

Baxter to Split Medical and Biotech Businesses in 2015

Novo Nordisk Sees Chance of U.S. Tresiba Launch Before Rivals

EU Looks to Speed Drug Access With Staggered Approval

127 more articles

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Virtual Event

Digitalization in the Chemical Industry

CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Novartis International AG

Blue Sphere Health Ltd.

EMG The European Marketing Group BV

Agilent Technologies Inc.

LOXXESS PHARMA GMBH

Brenntag SE

Porsche Consulting

AstraZeneca

PolarixPartner GmbH

IMCD Group B.V.

Asahi Kasei Europe

Aenova Holding GmbH

Bayer AG - Pharmaceuticals Communications & Health Policy

Packaging Coordinators, Inc.

SchüllerConsulting

Roche Group

Sanofi S.A.

CHEManager International c/o Wiley-VCH GmbH

gempex GmbH – THE GMP-EXPERT

Adragos Pharma

Harke Group GmbH

Pfizer, Inc.

Vetter Pharma International GmbH

GETEC Group

Thermo Fisher Scientific

Oxford Instruments

WuXi AppTec

VCI Verband Chem.- Ind. e.V

ISPE D/A/CH e.V.

Gilead Sciences, Inc.

AmbioPharm, Inc.

Thomson Reuters

CordenPharma International

Symbiosis Pharmaceutical Services